Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Administration of TAA-Specific CTLs; Hodgkin or Non-Hodgkin Lymphoma; TACTAL (TACTAL)

This study is currently recruiting participants. (see Contacts and Locations)
Verified September 2016 by Baylor College of Medicine
Center for Cell and Gene Therapy, Baylor College of Medicine
Texas Children's Hospital
The Methodist Hospital System
National Cancer Institute (NCI)
Information provided by (Responsible Party):
George Carrum, Baylor College of Medicine Identifier:
First received: April 7, 2011
Last updated: September 21, 2016
Last verified: September 2016
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: January 2019
  Estimated Primary Completion Date: January 2018 (Final data collection date for primary outcome measure)